1-4 of 4
Cedric John Carter, MD
Close
Sort by
Journal Articles

A Novel Polymer Based Antidote for Reversing the Anticoagulation Effect of Clinically Used Heparins,

Rajesh A Shenoi, PhD, Benjamin F L Lai, MSc, Dirk Lange, PhD, Donald E Brooks, PhD, Ben Chew, MD, Cedric John Carter, MD, Jayachandran N Kizhakkedathu, PhD
Journal: Blood
Blood (2011) 118 (21): 3359.
https://doi.org/10.1182/blood.V118.21.3359.3359
Published: 2011
Journal Articles

Identification of a Novel Coagulation Factor X Compound Heterozygous Mutation Associated with Differential Initiating Clotting Pathway Function.

Amanda L Vanden Hoek, BSc, Kimberley Talbot, MPhil, Isis Carter, BSc, Linda Vickars, MD, FRCP(C), Cedric John Carter, MD, Ross T.A. MacGillivray, PhD, Ed L.G. Pryzdial, PhD
Journal: Blood
Blood (2010) 116 (21): 1129.
https://doi.org/10.1182/blood.V116.21.1129.1129
Published: 2010
Journal Articles

Identification and Cloning of Novel Mutations In a Compound Heterozygous Factor V Deficient Patient

Kimberley Talbot, MPhil, Jina Song, PhD, Lily Eghdami, Jessica Tamura-Wells, Jeff Hewitt, PhD, Linda Vickars, MD, FRCP(C), Cedric John Carter, MD, Ross T.A. MacGillivray, PhD, Ed L.G. Pryzdial, PhD
Journal: Blood
Blood (2010) 116 (21): 2210.
https://doi.org/10.1182/blood.V116.21.2210.2210
Published: 2010
Journal Articles

Molecular Basis for A Thrombophilic Patient's Combined Deficiencies in Proteins C and S.

Tyler W Smith, MD, Isis S. R Carter, BSc, PGDipSci, Cedric John Carter, MD, Ross T.A MacGillivray, PhD
Journal: Blood
Blood (2009) 114 (22): 4198.
https://doi.org/10.1182/blood.V114.22.4198.4198
Published: 2009